Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
In July 2020, the U.S. Food and Drug Administration approved decitabine and cedazuridine (Inqovi®) tablets for the treatment of adults with myelodysplastic syndromes (MDS).